543 related articles for article (PubMed ID: 31817718)
21. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
[TBL] [Abstract][Full Text] [Related]
22. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms.
Ye MX; Zhao YL; Li Y; Miao Q; Li ZK; Ren XL; Song LQ; Yin H; Zhang J
Phytomedicine; 2012 Jun; 19(8-9):779-87. PubMed ID: 22483553
[TBL] [Abstract][Full Text] [Related]
23. Curcumin induces apoptosis and suppresses invasion through MAPK and MMP signaling in human monocytic leukemia SHI-1 cells.
Zhu GH; Dai HP; Shen Q; Ji O; Zhang Q; Zhai YL
Pharm Biol; 2016 Aug; 54(8):1303-11. PubMed ID: 26134921
[TBL] [Abstract][Full Text] [Related]
24. Molecular Mechanisms of Anti-metastatic Activity of Curcumin.
Deng YI; Verron E; Rohanizadeh R
Anticancer Res; 2016 Nov; 36(11):5639-5647. PubMed ID: 27793885
[TBL] [Abstract][Full Text] [Related]
25. Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury.
Ashrafizadeh M; Ahmadi Z; Mohammadinejad R; Farkhondeh T; Samarghandian S
Curr Mol Med; 2020; 20(2):116-133. PubMed ID: 31622191
[TBL] [Abstract][Full Text] [Related]
26. The multifaceted role of curcumin in cancer prevention and treatment.
Shanmugam MK; Rane G; Kanchi MM; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Tan BK; Kumar AP; Sethi G
Molecules; 2015 Feb; 20(2):2728-69. PubMed ID: 25665066
[TBL] [Abstract][Full Text] [Related]
27. Curcumin and its formulations: potential anti-cancer agents.
Ji JL; Huang XF; Zhu HL
Anticancer Agents Med Chem; 2012 Mar; 12(3):210-8. PubMed ID: 22044005
[TBL] [Abstract][Full Text] [Related]
28. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
Bashang H; Tamma S
Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
[TBL] [Abstract][Full Text] [Related]
29. Curcumin: updated molecular mechanisms and intervention targets in human lung cancer.
Ye MX; Li Y; Yin H; Zhang J
Int J Mol Sci; 2012; 13(3):3959-3978. PubMed ID: 22489192
[TBL] [Abstract][Full Text] [Related]
30. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic applications of curcumin for patients with pancreatic cancer.
Kanai M
World J Gastroenterol; 2014 Jul; 20(28):9384-91. PubMed ID: 25071333
[TBL] [Abstract][Full Text] [Related]
32. Curcumin targets in inflammation and cancer.
Deguchi A
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):88-96. PubMed ID: 25772169
[TBL] [Abstract][Full Text] [Related]
33. Curcumin (Turmeric) and cancer.
Unlu A; Nayir E; Dogukan Kalenderoglu M; Kirca O; Ozdogan M
J BUON; 2016; 21(5):1050-1060. PubMed ID: 27837604
[TBL] [Abstract][Full Text] [Related]
34. Curcumin inhibits the proliferation and induces apoptosis in HT-29 cell lines through a reactive oxygen species (ROS)-dependent mechanism.
Wang J; Qi L; Mei L; Wu Z
Pak J Pharm Sci; 2017 Sep; 30(5):1671-1677. PubMed ID: 29084689
[TBL] [Abstract][Full Text] [Related]
35. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways.
Zhen L; Fan D; Yi X; Cao X; Chen D; Wang L
Int J Clin Exp Pathol; 2014; 7(10):6438-46. PubMed ID: 25400722
[TBL] [Abstract][Full Text] [Related]
36. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
[TBL] [Abstract][Full Text] [Related]
37. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.
Moon DO
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474160
[TBL] [Abstract][Full Text] [Related]
38. Cell growth regulation.
Karunagaran D; Joseph J; Kumar TR
Adv Exp Med Biol; 2007; 595():245-68. PubMed ID: 17569215
[TBL] [Abstract][Full Text] [Related]
39. Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal BB; Kumar A; Bharti AC
Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling.
Zhan Y; Chen Y; Liu R; Zhang H; Zhang Y
Arch Pharm Res; 2014 Aug; 37(8):1086-95. PubMed ID: 24318305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
